البلد: أستراليا
اللغة: الإنجليزية
المصدر: APVMA (Australian Pesticides and Veterinary Medicines Authority)
CEFTIOFUR AS CEFTIOFUR CRYSTALLINE FREE ACID
ZOETIS AUSTRALIA PTY LTD
ceftiofur (acid)(200mg/mL)
PARENTERAL LIQUID/SOLUTION/SUSPENSION
CEFTIOFUR AS CEFTIOFUR CRYSTALLINE FREE ACID ANTIBIOTIC Active 200.0 mg/ml
100 mL; 250 mL
VM - Veterinary Medicine
ZOETIS AUSTRALIA
CATTLE | BEEF | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | COW | DAIRY COW | HEIFER | STEER
ANTIBIOTIC & RELATED
BOVINE RESPIRATORY DISEASE | SHIPPING FEVER
Poison schedule: 4; Withholding period: WITHHOLDING PERIODS MEAT: DO NOT USE l ess than 14 days before slaughter for human consumption. Calves born to cows that were treated during pregnancy mu st not be slaughtered for human consump tion for 14 days after treatment of the dam. MILK: Milk may be collected and processed for human consumption at any time after treatment. DO NOT SLAUGHTE R for export less than 14 days after tr eatment. Calves born to cows that were treated during pregnancy must not be s laughtered for export for 14 days afte r treatment of the dam.; Host/pest details: CATTLE: [BOVINE RESPIRATORY DISEASE]; Poison schedule: 4; Withholding period: ; Host/pest details: CATTLE: [BOVINE RESPIRATORY DISEASE]; For the treatment of bovine bacterial diseases caused by Mannheimia haemolytica, Pasteurella multocida & Histophilus somni.See Restraints & WITHHOLDING PERIODS on leaflet.
Registered
2023-07-01
Product Name: APVMA Approval No: EXCEDE STERILE SUSPENSION 65092/126405 Label Name: EXCEDE STERILE SUSPENSION Signal Headings: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY READ SAFETY DIRECTIONS Constituent Statements: 200 mg/mL CEFTIOFUR as Ceftiofur Crystalline Free Acid Claims: For the treatment of bovine bacterial respiratory diseases caused by _Mannheimia _ _haemolytica, Pasteurella multocida_ and_ Histophilus somni. _ Resistance may develop to any antibiotic. Net Contents: 100 mL, 250 mL Directions for Use: Restraints: ADMINISTER ONLY by injection in base of ear. DO NOT re-treat animals less than 28 days after the last injection. DO NOT USE for mass medication: for individual animal treatment only. DO NOT USE for the treatment of mastitis in dairy cattle. Contraindications: As with all drugs, the use of EXCEDE Sterile Suspension is contra-indicated in animals previously found to be hypersensitive to the drug. Precautions: Side Effects: Dosage and Administration: SHAKE WELL BEFORE USING Discard unused contents within 28 days of initial vial broaching. Administer one dose as a single subcutaneous injection in the posterior aspect of the ear where it attaches to the head (base of the ear) to cattle at a dosage of 6.6mg/kg body weight (3.3mL per 100 kg body weight). RLP APPROVED Most animals will respond to treatment within three to five days. If no improvement is observed, the diagnosis should be re-evaluated. Administration Technique Base of the Ear • Hold the syringe and needle behind the ear so the needle and syringe point in the direction of an imaginary line that would pass through the head toward the animal’s opposite eye. See Figures 1 and 2. • Insert the needle through the loose skin in the posterior aspect of the ear where it attaches to the head (base of the ear) while maintaining this angle. See Figure 1. • Deliver the entire contents of the syringe. FIGURE 1: Subcutaneous administration of EXCEDE Sterile Suspension at the posterior aspect of the ear whe اقرأ الوثيقة كاملة
PRODUCT NAME: EXCEDE® STERILE SUSPENSION PAGE: 1 OF 5 THIS REVISION ISSUED: FEBRUARY, 2012 MATERIAL SAFETY DATA SHEET Issued by: Pfizer Australia Pty Ltd Phone: 1800 814 883 POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER Pfizer Australia Pty Ltd 38-42 Wharf Road West Ryde NSW 2114 Tel: 1800 814 883 Fax: (02) 9850 3399 ____________________________________ PFIZER AUSTRALIA PTY LTD A.B.N. 50 008 422 348 CHEMICAL NATURE: Antibiotic in a suitable vehicle. Injectable. TRADE NAME: EXCEDE ® STERILE SUSPENSION APVMA CODE: 65092 PRODUCT USE: Veterinary product used as an antibiotic. Not for human use. CREATION DATE: FEBRUARY, 2012 THIS VERSION ISSUED: FEBRUARY, 2012 and is valid for 5 years from this date. SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Xi, Irritating. Hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: R42/43. May cause sensitisation by inhalation and skin contact. SAFETY PHRASES: S28, S24/25. After contact with skin, wash immediately with plenty of soap and water. Avoid contact with skin and eyes. SUSMP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated E E E M M M E E E R R R G G G E E E N N N C C C Y Y Y O O O V V V E E E R R R V V V I I I E E E W W W PHYSICAL DESCRIPTION & COLOUR: Suspension. ODOUR: Musty odour. MAJOR HEALTH HAZARDS: may cause sensitisation by inhalation and skin contact. This is an antibiotic preparation. Any person with a history of allergies to this class of substances (especially penicillin and cephalosporin) should avoid contact with this product as it may cause sensitisation. اقرأ الوثيقة كاملة